^18F-FDG PET/CT在卵巢癌复发和转移上的临床价值  

The clinical value of ^18F - FDG PET / CT in ovarian cancer recurrence and metastasis

作　　者：于丽娟[1] 徐继有[1] 李迎辞[1] 楚春雨[1] 

机构地区：[1]哈尔滨医科大学附属肿瘤医院PET/CT中心,哈尔滨150081

出　　处：《实用肿瘤学杂志》2013年第3期211-214,共4页Practical Oncology Journal

基　　金：基金项目：黑龙江省教育厅科学技术研究项目（12511326）

摘　　要：在妇科肿瘤患者中，卵巢癌具有较高的发病率以及复发率。早期发现卵巢癌局部复发或远处转移，对临床治疗方案的制定、患者的生存期和生存质量意义重大。与CT和MRI相比，18F-脱氧葡萄糖（FDG） PET/CT在卵巢癌复发和转移的探测方面具有较高的敏感性和特异性，而且18F-FDG PET/CT可以早期监测和评估放疗和化疗后的效果，对于卵巢癌的后续治疗意义较大。本文就18F-FDG PET/CT在卵巢癌复发、转移、评价疗效和预后判断等方面的临床价值做一综述。Ovarian cancer has a high morbidity and recurrence rate in gynecological tumors. It has great significance to clinical program development and the patient＇s survival and quality of life that the early detection of local recurrence or distant metastasis. The ^18F - FDG PET/CT has higher sensitivity and specificity than CT or MRI in the detection of ovarian cancer recurrence and metastasis, early monitoring and evaluation the effect of after radiotherapy and chemotherapy. It is significance for follow - up treatment of ovarian cancer. This paper reviewed the principle and clinical utility of ^18F - FDG PET/CT in recurrence, metastasis, therapeutic response as well as prognosis of ovarian cancer.

关 键 词：卵巢癌 体层摄影术 发射性计算机 脱氧葡萄糖 

分 类 号：R737.31[医药卫生—肿瘤]